From Diagnosis To Cure Innovations In Disease Diagnosis And Treatment

Chapter1: Advancements in diagnosis and treatment of neurological disorders Chapter2: Advancements in diagnosis and treatment of mental disorders Chapter3: Advancements in diagnosis and treatment of cardiovascular disease Chapter4: Advancements in surgical procedures Chapter5: New developments in surgical procedures

Neurodegenerative disease occurs when the nerve cells of the brain and peripheral nervous system lose their function over time and eventually die. Currently, there are no cures that can permanently cure or slow down the progression of these diseases. The risk of developing neurodegenerative diseases increases dramatically with age. Parkinson's and Alzheimer's disease are the two most common neurodegenerative diseases. The risk factor for neurodegenerative diseases is a combination of environmental and genetic factors. A person might have a gene that can make them more susceptible to a particular neurodegenerative disease. But the time and severity of the disease depends on the environmental exposures throughout life. This book presents the complex subject of neurodegenerative diseases in the most comprehensible and easy to understand language. It is compiled in such a manner, that it will provide in-depth knowledge about the innovations in diagnosis and therapy of these diseases. This book will provide comprehensive knowledge to the readers.

Getting the right diagnosis is a key aspect of health care - it provides an explanation of a patient's health problem and informs subsequent health care decisions. The diagnostic process is a complex, collaborative activity that involves clinical reasoning and information gathering to determine a patient's health problem. According to Improving Diagnosis in Health Care, diagnostic errors-inaccurate or delayed diagnoses-persist throughout all settings of care and continue to harm an unacceptable number of patients. It is likely that most people will experience at least one diagnostic error in their lifetime, sometimes with devastating consequences. Diagnostic errors may cause harm to patients by preventing or delaying appropriate treatment, providing unnecessary or harmful treatment, or resulting in psychological or financial repercussions. The committee concluded that improving the diagnostic process is not only possible, but also represents a moral, professional, and public health imperative. Improving Diagnosis in Health Care, a continuation of the landmark Institute of Medicine reports To Err Is Human (2000) and Crossing the Quality Chasm (2001), finds that diagnosis-and, in particular, the occurrence of diagnostic errorsâ€"has been largely unappreciated in efforts to improve the quality and safety of health care. Without a dedicated focus on improving diagnosis, diagnostic errors will likely worsen as the delivery of health care and the diagnostic process continue to increase in complexity. Just as the diagnostic process is a collaborative activity, improving diagnosis will require collaboration and a widespread commitment to change among health care professionals, health care organizations, patients and their families, researchers, and policy makers. The recommendations of Improving Diagnosis in Health Care contribute to the growing momentum for change in this crucial area of health care quality and safety.

The very rapid pace of advances in biomedical research promises us a wide range of new drugs, medical devices, and clinical procedures. The extent to which these discoveries will benefit the public, however, depends in large part on the methods we choose for developing and testing them. Modern Methods of Clinical Investigation focuses on strategies for clinical evaluation and their role in uncovering the actual benefits and risks of medical innovation. Essays explore differences in our current systems for evaluating drugs, medical devices, and clinical procedures; health insurance databases as a tool for assessing treatment outcomes; the role of the medical profession, the Food and Drug Administration, and industry in stimulating the use of evaluative methods; and more. This book will be of special interest to policymakers, regulators, executives in the medical industry, clinical researchers, and physicians.